Home | Publications | Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort

Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort

Published on: 22 February, 2021

Lamb MJ, Smith A, Painter D, Kane E, Bagguley T, Newton R, et al. Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort. BMJ Open. 2021 Feb 22;11(2):e041296

Link to Publication

Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort

Published on: 22 February, 2021

Related Themes

Oncology

Related Team Members

Professor Gordon Cook

Clinical Director and Oncology Theme Lead